A study conducted by Roland Berger of 50 top drug industry executives showed a pattern of large pharmaceutical companies moving away from development of patented drugs as concern about the returns from future innovation mounts. The survey showed significantly different approaches to diversification, with 67% viewing diversification as a potential solution. France’s Sanofi-Aventis is among […]
The World Steel Association’s October 2010 short-range outlook for 2010 and 2011 forecasts that global apparent steel use (deliveries of steel from domestic producers and importers and not from inventories) will increase 13.1% to 1,272 million metric tons (mmt) in 2010 after decreasing by 6.6% last year. World steel demand is expected to grow 5.3% […]
IMS Health forecasts the global pharmaceutical market will reach $880 billion in 2011, growing 5%–7%, compared with 4%–5% in 2010. The overall market is projected to rebound, but factors that prohibit growth, including major patent expirations and payer mechanisms to curb drug spending, will be stronger than ever. Drug sales in the 17 pharmerging countries […]
The number of US biotech companies has decreased by 25% in the past three years. Fifty-five biotech companies were acquired in 2008, up from 40 in 2007. In 2009, 38 companies were acquired. So far this year, there have been 21 acquisitions of biotech companies. Despite the decrease, the approximately 294 public biotech companies are […]
Contract research organizations (CROs) are increasingly entering into long-term contracts with pharmaceutical companies under which they provide multiple services. GlaxoSmithKline has just announced negotiations with Parexel International for such a partnership and stated that it plans to reduce the number of the CROs it works with from 30 to a few. Parexel also has long-term […]
Worldwide semiconductor capital equipment spending is projected to approach $36.9 billion in 2010, a 122.1% increase. Strong spending by the foundry and logic segments of the market, combined with a technology upgrade for memory manufacturers, has led to capital expenditure currently being above 95%, quite an increase from 2009, when it dropped 41.2% to $16.6 […]
A September report by the World Intellectual Property Organization (WIPO) shows that innovative activity and demand for intellectual property rights decreased during the global economic crisis, but is now returning. In 2008, the number of patent application filings increased 2.6%, the slowest rate since the early 2000s, but the number of Chinese patent applications grew […]
Fifty-eight biopharmaceuticals were approved by the US and the EU from January 2006 to June 2010. These include 30 hormones, growth factors and other regulatory molecules; 13 mAb-based products; four blood-related proteins; two subunit vaccines; and nine other biopharmaceuticals, including fusion proteins and therapeutic enzymes. Twenty-five of these products were new biopharmaceuticals, as opposed to […]
When the US stimulus ends September 30, academic research could suffer. The NIH has funded 18,568 biomedical research projects with the $8.2 billion it received over two years from the stimulus. Its annual grant and contract budget could drop by about 15%, going by this year’s appropriation of $26.2 billion. Universities that have received the […]
A new nationwide research initiative, launched by the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health (NIH), hopes to improve vaccines and therapeutics. The NIH will allocate $100 million over five years to conduct the research at six Human Immune Phenotyping Centers—Baylor Research Institute, Dana-Farber Cancer Institute, Emory […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
